INSCoV-601I (1)
INSCoV-601I (1) is a potent inhibitor of Mpro (3CLpro) . Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-601I (1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) [1].
Product Specifications
CAS Number
2735704-19-3
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/inscov-601i-1.html
Solubility
10 mM in DMSO
Smiles
ClCC(N(C1=CC=C(C2=CC=NS2)C=C1)[C@H](C3=NC=CN=C3)C(NC4CCC(F)(CC4)F)=O)=O
Molecular Formula
C23H22ClF2N5O2S
Molecular Weight
505.97
References & Citations
[1]Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3540), CF740 conjugate, 0.1mg/mL
Neuronal membrane glycoprotein M6 a (GPM6A) (NM_201592) Human Recombinant Protein
